4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-18-039187
Options or other derivatives
- President and CEO acquired 1,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schwieterman William D President and CEO | 2018-06-20 | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | D | ||
| Schwieterman William D President and CEO | 2018-06-20 | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | D | ||
Loading xslF345X03/doc4.xml…